Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SNSE/JNJ stock hub

SNSE/JNJ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SNSE/JNJis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

475T

Santiago Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SNSE/JNJ

In the news

Latest news · SNSE/JNJ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.6

P25 13.4P50 16.4P75 18.1

Trailing P/E24.4

P25 22.5P50 24.4P75 24.4

ROE26.4

P25 9.9P50 12.3P75 18.9

ROIC19.9

P25 12.7P50 13.8P75 19.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SNSE/JNJ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CL
Employees	138,200
Employees Change	6,200%
Employees Change Percent	4.7
Enterprise value	$504.3T
Exchange	Santiago Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	$475T
Price	$217
Price currency	USD
Rev Per Employee	643,892,696.89x
Sector	Healthcare
Sic	2834
Symbol	snse/JNJ
Website	https://www.jnj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.09%
EV Earnings	25.96x
EV/EBIT	21.27x
EV/EBITDA	16.39x
EV/FCF	30.71x
EV/Sales	5.87x
FCF yield	3.46%
Forward P/E	18.56x
P/B ratio	6.34x
P/E ratio	24.45x
P/S ratio	5.34x
PE Ratio10 Y	45.82x
PE Ratio3 Y	18.63x
PE Ratio5 Y	21.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.59%
EBITDA Margin	35.62%
FCF margin	18.46%
Gross margin	68.04%
Gross Profit	$60.5T
Gross Profit Growth	6.69%
Gross Profit Growth Q	9.85%
Gross Profit Growth3 Y	6.7%
Gross Profit Growth5 Y	3.28%
Net Income	$19.4T
Net Income Growth	-3.53%
Net Income Growth Q	-52.41%
Net Income Growth3 Y	18.25%
Net Income Growth5 Y	6.84%
Pretax Margin	25.88%
Profit Margin	21.83%
Profit Per Employee	$140.6M
ROA	8.42
Roa5y	8.04
ROCE	18.57
ROE	26.42
Roe5y	24.21
ROIC	19.95
Roic5y	23.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.06%
Cagr1y	51.1%
Cagr3y	13.82%
Cagr5y	8.5%
Div CAGR10	8.99%
Div CAGR3	6.59%
Div CAGR5	9.16%
EPS Growth	-3.89
EPS Growth Q	-52.86
EPS Growth3 Y	21.64
EPS Growth5 Y	8.81
FCF Growth	-12.7%
FCF Growth Q	-56.64%
FCF Growth3 Y	3.14%
FCF Growth5 Y	-3.13%
OCF Growth	-7.72%
OCF Growth Q	-39.77%
OCF Growth10 Y	1.93%
OCF Growth3 Y	3.76%
OCF Growth5 Y	-1.17%
Revenue Growth	7.87x
Revenue Growth Q	9.91x
Revenue Growth3 Y	7.55x
Revenue Growth5 Y	2.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.49
Assets	$185.5T
Cash	$20.4T
Current Assets	$52.7T
Current Liabilities	$51.4T
Debt	$50.8T
Debt EBITDA	$1.59
Debt Equity	$0.68
Debt FCF	$3.09
Equity	$75T
Interest Coverage	25.59
Liabilities	$110.5T
Long Term Assets	$132.8T
Long Term Liabilities	$59.1T
Net Cash	$-30.4T
Net Cash By Market Cap	$-6.4
Net Debt EBITDA	$0.96
Net Debt Equity	$0.41
Net Debt FCF	$1.85
Tangible Book Value	$-15.2T
Tangible Book Value Per Share	$-6,306
WACC	7.26

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.03
Inventory Turnover	2.26
Net Working Capital	$-2.9T
Quick ratio	0.69
Working Capital	$1.3T
Working Capital Turnover	$11,051

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.29%
Dividend Growth	4.19%
Dividend Growth Years	2%
Dividend per share	$4,808
Dividend Years	14
Dividend Yield	2,210.96%
Ex Div Date	2026-02-24
Last Dividend	$1,120
Payout Frequency	Quarterly
Payout Ratio	59.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	185.31%
1Y total return	51.06%
200-day SMA	193.9
3Y total return	47.45%
50-day SMA	217.5
50-day SMA vs 200-day SMA	50over200
5Y total return	50.38%
All Time High	217.5
All Time High Change	0%
All Time High Date	2026-01-20
All Time Low	63.88
All Time Low Change	240.42%
All Time Low Date	2013-10-17
ATR	0.03
Beta	0.66
Ch YTD	13.83
High52	217.5
High52 Date	2026-05-08
High52ch	0%
Low52	144
Low52 Date	2025-05-26
Low52ch	51.06%
Ma50ch	0%
Price vs 200-day SMA	12.16%
RSI	100
RSI Monthly	92.07
RSI Weekly	99.92
Sharpe ratio	1.81x
Total Return	2,210.67%
Tr YTD	14.51
Tr3m	0.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$24.6T
Operating Income Growth	17.5
Operating Income Growth Q	4.05
Operating Income Growth3 Y	6.76
Operating Income Growth5 Y	4.61
Operating margin	27.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,403,389,742%
Net Borrowing	1,604,322,000,000
Shares Insiders	0.04%
Shares Institutions	75.42%
Shares Qo Q	0.25%
Shares Yo Y	0.29%
Short Ratio	2.44

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$15.2T
Average Volume	0x
Bv Per Share	31,152.7
CAPEX	$-4.7T
Ch10y	115.7
Ch1y	46.67
Ch3y	34.42
Ch5y	30.11
Ch6m	13.83
Change	0%
Close	217.5
Depreciation Amortization	6,894,128,150,000
Earnings Date	2026-04-14
EBIT	$24.6T
EBITDA	$31.7T
EPS	$7,974
F Score	5
FCF	$16.4T
FCF EV Yield	3.26x
Financing CF	-14,249,834,105,000
Fiscal Year End	December
Founded	1,886
Goodwill	43,279,259,820,000
Graham Number	82.89292
Graham Upside	-61.88
Income Tax	$3.6T
Investing CF	-22,468,583,605,000
Is Primary Listing	0
Last Earnings Date	2026-04-14
Last Report Date	2026-03-29
Lynch Fair Value	$60.84
Lynch Upside	-72.03
Ma150	203.6
Ma150ch	6.8%
Ma20	217.5
Ma20ch	0%
Net CF	-15,501,115,630,000
Next Earnings Date	2026-07-14
P FCF Ratio	28.92
P OCF Ratio	22.49
Payment Date	2026-03-10
Ppne	20,740,318,300,000
Price Date	2026-05-08
Price EBITDA	$14.98
Relative Volume	2,000x
Revenue	88,985,970,710,000x
SBC By Revenue	1.42x
Share Based Comp	1,261,439,530,000
Tax By Revenue	4.05x
Tax Rate	15.64%
Tr6m	15.3%
Z Score	4.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SNSE/JNJ dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2211.0%

$4808 annual per share

Payout ratio

+59.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.2%

2 consecutive years of growth

Total shareholder yield

+2210.7%

Next ex-dividend date: 2026-02-24

Performance

SNSE/JNJ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SNSE/JNJ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+75.4%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SNSE/JNJ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

100.0

Above 70: short-term overbought

Price vs 200-day MA

+12.2%

50/200-day relationship not available

Beta (5Y)

0.66

Less volatile than the market

Sharpe ratio

1.81

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SNSE/JNJ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current snse/JNJ stock rating?

snse/JNJ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full snse/JNJ analysis?

The full report lives at /stocks/snse/JNJ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for snse/JNJ?

The latest report frames snse/JNJ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the snse/JNJ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.